RLY-4008
Relay Therapeutics
[]
 88% overall response rate (15 out of 17) from interim data of pan-fgfr treatment (fgfri)-na ve fgfr2-fusion cholangiocarcinoma (cca) patients treated at the pi...
Fan of #Bioteh, #Tech and #Crypto.  Love #AI/#ML, #CRISPR, #CellEnginnering, #SynBio and #iPSC in Biotech. Love #Fintech, #Automation and #EV in tech.